nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlormezanone—TSPO—epithelium—vaginal cancer	0.132	0.132	CbGeAlD
Chlormezanone—TSPO—uterine cervix—vaginal cancer	0.131	0.131	CbGeAlD
Chlormezanone—TSPO—urethra—vaginal cancer	0.12	0.12	CbGeAlD
Chlormezanone—TSPO—endometrium—vaginal cancer	0.118	0.118	CbGeAlD
Chlormezanone—TSPO—mammalian vulva—vaginal cancer	0.114	0.114	CbGeAlD
Chlormezanone—TSPO—uterus—vaginal cancer	0.109	0.109	CbGeAlD
Chlormezanone—TSPO—female reproductive system—vaginal cancer	0.098	0.098	CbGeAlD
Chlormezanone—TSPO—female gonad—vaginal cancer	0.0891	0.0891	CbGeAlD
Chlormezanone—TSPO—vagina—vaginal cancer	0.0886	0.0886	CbGeAlD
